@article{5e7bd78b4c8a4253b48f2544a51f4057,
title = "EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence Network",
abstract = "The European Academy of Allergy and Clinical Immunology (EAACI) is the leading organisation in the field of Allergy, Asthma and Clinical Immunology with nearly 12,000 members from 124 countries and works with over 70National Allergy Societies. It is the primary source of expertise in Europe and worldwide for all aspects of allergic diseases and asthma. Recent efforts by EAACI resulted in a successful Strategic Forum on Allergic Diseases (1), with key opinion leaders acknowledging the impact of translational research in cultivating multidirectional and multidisciplinary integration of basic research as well as patient-oriented, population-based studies, with the long-term objective of improving the management of allergic diseases and asthma.",
keywords = "allergy diagnosis, allergy treament, biomarkers, clinical immunology, food allergy",
author = "Shamji, {Mohamed H} and CezmiA Akdis and Domingo Barber and Walter Canonica and Tom{\'a}s Chivato and {Del Giacco}, Stefano and Karin Hoffman-Sommergruber and Marek Jutel and Edward Knol and Markus Ollert and Liam O'Mahony and Oscar Palomares and Joaquin Sastre and J{\"u}rgen Schwarze and SylwiaSmolinska and Stephan Vieths and IoanaAgache",
note = "Funding Information: Dr Vieths reports personal fees from {\"A}rzteverband Deutscher Allergologen, personal fees from Swiss Society for Allergy and Immunology, personal fees from Schattauer Allergologie Handbuch, personal fees from Elsevier Nahrungsmittelallergien und Intoleranzen, personal fees from Karger Food Allergy: Molecular Basis and Clinical Practice, nonfinancial support from German Research Foundation, nonfinancial support from European Directorate for the Quality of Medicines and Health Care, nonfinancial support from European Academy of Allergy and Clinical Immunology, nonfinancial support from German Chemical Society (GDCh), nonfinancial support from AKM Allergiekongress, nonfinancial support from International Union of Immunological Societies, personal fees from Pharmacon, nonfinancial support from Spanish Society for Allergy and Clinical Immunology (SEAIC), outside the submitted work; Dr Jutel reports personal fees from ALK‐Abello, personal fees from Allergopharma, personal fees from Stallergenes, personal fees from Anergis, personal fees from Allergy Therapeutics, personal fees from Circassia, personal fees from Leti, personal fees from Biomay, personal fees from HAL, during the conduct of the study; personal fees from Astra‐Zeneka, personal fees from GSK, personal fees from Novartis, personal fees from Teva, personal fees from Vectura, personal fees from UCB, personal fees from Takeda, personal fees from Roche, personal fees from Janssen, personal fees from Medimmune, personal fees from Chiesi, outside the submitted work; Dr Del Giacco has nothing to disclose. Dr Hoffmann‐Sommergruber reports grants from Austrian Science Funds (FWF), grants from EU‐Horion 7, other from EAACI, personal fees from HESI, outside the submitted work; Dr Knol has nothing to disclose. Dr Smolinska has nothing to disclose. Dr Palomares has received research grants from Inmunotek SL, and Novartis Oscar Palomares has received fees for giving scientific lectures from: Allergy Therapeutics, Amgen, AstraZeneca, Diater, GlaxoSmithKline S.A, Inmunotek S.L, Novartis, Sanofi‐Genzyme and Stallergenes Oscar Palomares has participated in advisory boards from Novartis and Sanofi‐Genezyme. Dr Ollert reports personal fees from Hycor Diagnostics, personal fees from Thermo Fisher Scientific, outside the submitted work; Dr O'Mahony reports personal fees from Alimentary Health, grants from GSK, outside the submitted work. Dr BARBER reports personal fees from ALK, personal fees from AIMMUNE, outside the submitted work; Dr CANONICA has nothing to disclose. Dr Schwarze has nothing to disclose. Dr Agache reports and Associate Editor Allergy journal. Dr SASTRE reports grants and personal fees from SANOFI, personal fees from GSK, personal fees from FAES FARMA, personal fees from LETI, personal fees from MUNDIPHARMA, personal fees from NOVARTIS, grants from ALK, outside the submitted work;. Dr Chivato has nothing to disclose. Dr Akdis reports grants from Allergopharma, Idorsia, Swiss National Science Foundation, Christine K{\"u}hne‐Center for Allergy Research and Education, European Commission's Horison's 2020 Framework Programme, Cure, Novartis Research Institutes, Astra Zeneca, Scibase, advisory role in Sanofi/Regeneron, outside the submitted work. Dr Jutel reports personal fees from ALK‐Abello, personal fees from Allergopharma, personal fees from Stallergenes, personal fees from Anergis, personal fees from Allergy Therapeutics, personal fees from Circassia, personal fees from Leti, personal fees from Biomay, personal fees from HAL, during the conduct of the study; personal fees from Astra‐Zeneka, personal fees from GSK, personal fees from Novartis, personal fees from Teva, personal fees from Vectura, personal fees from UCB, personal fees from Takeda, personal fees from Roche, personal fees from Janssen, personal fees from Medimmune, personal fees from Chiesi, outside the submitted work.",
year = "2020",
month = aug,
doi = "10.1111/all.14340",
language = "English",
volume = "75",
pages = "1899--1901",
journal = "Allergy",
issn = "0105-4538",
publisher = "Wiley-Blackwell",
number = "8",
}